View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Nymi™
11 June 2018

Authentication Solution Improves Data Integrity For Manufacturing Environments

Highly regulated manufacturing operations must control access to devices, applications and physical spaces to ensure data integrity, compliance and security without compromising productivity. Nymi is bringing a new innovative authentication solution to these operations with the Nymi Enterprise Edition.

Nymi Enterprise Edition authentication is a comprehensive solution consisting of a multi-factor biometrically authenticated wearable (the Nymi Band) and a complete enterprise system for administration, management and integration into existing identity ecosystems. It provides the industry’s first enterprise-grade authentication solution that addresses data integrity and compliance concerns.

Unlike security measures that rely on passwords, pins or tokens that can be lost, shared or stolen, the Nymi Band features both fingerprint and electrocardiogram (ECG) sensors to ensure the user authenticating is indeed the correct person. The on-body detection adds another layer of assurance for accomplishing non-repudiation of actions in highly regulated manufacturing processes.

The Nymi Enterprise Edition integrates with existing identity access management (IAM) and manufacturing execution systems (MES) to accomplish digital signatures and store electronic batch records. With easier, more secure and efficient non-repudiation mechanisms, Nymi Enterprise Edition enables users to significantly reduce deviations and compliance costs related to 21 CFR Part 11.

Chief operating officer at Nymi Dave Rai says: “Nymi solves the most critical problems around data integrity, compliance and user non-repudiation driving the shift toward Industry 4.0.

“By moving to an ‘on-body, always on’ authentication model, users of the Nymi Enterprise Edition realise significant improvements in data integrity, security and productivity. With the Nymi Enterprise Edition, deployment is quick and easy as the architecture leverages the existing MES and IAM infrastructure.”

To further ease integration, Nymi has partnered with leading life sciences providers, including Werum and Evidian. This partnership is helping provide seamless integration with Werum’s PAS-X MES and Evidian’s E-SSO flexible Single-Sign On solution.

Senior head of account and programme management at Werum Florian Grabow said: “We are impressed by this great new idea of biometric user authentication and believe that it is a perfect addition to our PAS-X MES application. Not only will it help strengthen our customer’s data integrity, but it will also help address compliance requirements in pharma production.”

Chief operating officer at Evidian Sébastien Brachet said: “Nymi is an innovative authentication solution selected by Evidian since its creation for its very high level of simplicity for the user and security for the enterprise. Nymi Enterprise Edition provides companies with a multi-factor authentication solution that is both highly secure and easy-to-use.

“Nymi Enterprise Edition will allow our clients operating in highly regulated environments, such as laboratories, to continuously improve their user experience and satisfaction.”

Implement social distancing policies with real-time feedback to ensure the health and safety of workers, and analyse logs to identify high-risk behaviours.
Increasingly, organisations are integrating workplace wearables to help drive business objectives and operational efficiencies.
Every day, we are developing more and more sophisticated technology, but still connect to these systems in antiquated ways that have proven issues around security,...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology